Page last updated: 2024-09-03

n-isobutyrylcysteine and Idiopathic Parkinson Disease

n-isobutyrylcysteine has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Gao, G; He, M; Li, J; Sun, T; Wang, L1

Other Studies

1 other study(ies) available for n-isobutyrylcysteine and Idiopathic Parkinson Disease

ArticleYear
Gold nanoclusters for Parkinson's disease treatment.
    Biomaterials, 2019, Volume: 194

    Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Cysteine; Disease Models, Animal; Gold; Male; Mice, Inbred C57BL; Nanoparticles; Parkinson Disease; PC12 Cells; Rats

2019